Bone marrow mononuclear cell therapy for patients with cirrhosis: a Phase 1 study.

BACKGROUND Bone marrow-derived cell therapy has been investigated in patients with severe liver disease. AIMS To assess the feasibility, safety and cell kinetics of autologous bone marrow-derived mononuclear cells (BMMCs) infusion in cirrhotic patients. METHODS BMMCs were isolated from autologous bone marrow and 10% of the cells were labelled with (99m… CONTINUE READING